Related posts

Nervous markets await Nvidia
Investor Insights

This summary was created by AI, based on 3 opinions in the last 12 months.

Koninklijke Philips Electronics has faced significant challenges in recent years, particularly stemming from legal issues related to sleep apnea equipment, which have now been settled. Despite some stock recovery, the company continues to struggle with slow growth and underperformance in several key business areas. Experts note that it is currently in a restructuring phase, which has led to concerns about competition and declining profit margins. Overall, the sentiment reflects a cautious approach towards Philips, as many analysts suggest there are better investment opportunities available elsewhere, given its ongoing turnaround efforts and uncertainty about long-term outcomes.

Consensus
Sell
Valuation
Overvalued
DON'T BUY

Medical equipment. In trouble years ago with large sleep apnea settlement. Struggling since then. With everything down, better places to look.

SELL

He sold. Problems with CPAP machines, have since been settled. Slow growth, struggling on a number of fronts. Still in restructuring mode. Look elsewhere.

SELL

Lawsuits are behind them. Stock's rallied off lows, still a long way to go. Struggling in a number of its core businesses. Lots of competition, softer margins. Other places to go. Still in turnaround mode.

BUY ON WEAKNESS

Quality franchise.
Buy when share price low.
Believes better names to invest in.

DON'T BUY

Difficult time. Hasn't rationalized their business the way Siemens has. Needs to look at cost of capital of all businesses and get rid of non-core ones. No need to own. Instead, look at Siemens or US industrials.

WEAK BUY
It is on sale since there is a lawsuit regarding the CPAP machines which have been recalled. However the rest of the business is doing well. The risk is what the cost will be coming out of the lawsuit, but the risk/reward is OK. Buy for the longer term.
DON'T BUY
It's isn't run well. Prefers Danaher.
BUY
Hospital equipment supplier. Recall on certain products has caused lawsuits. Sees value with recent selloff of shares. Good time to buy shares.
DON'T BUY
Fairly significant decline, but hasn't floored yet. There's never just one cockroach. Interesting franchise at the right price. Need some kind of catalyst before he'd get excited. Stay away for now.
HOLD
No, it's not a European version of GE. Rather, PHG has done well, but their sleep apnea machine has gone into recall and attracted lawsuits. This is weighing on the stock, though long-term this is a good investment. Still happy to own it. But who knows how this or any lawsuit will end, and the overhang will continue over this stock.
BUY
Believes risk in Ukraine is regional and should not affect other parts of Europe. Conflict in Ukraine is presenting buying opportunities. Questions surrounding government spending on healthcare. Good company that is good to hold long term.
BUY
Medical technology. Fantastic job repositioning away from consumer products. Likes the company. Under pressure due to CPAP recall. An opportunity.
COMMENT
Remember that the CAD is very strong, so European names may look down in your account because of the currency. Well run. If the turnaround is executed correctly, there could be significant upside from these levels. European stocks are trading down because of Ukraine. If you're underwater, you may just want to sell and move on.
TOP PICK
They have grown into diagnostics equipment and connect care products. The stock is down due to a recall of their CPAP (sleep apnea) machines. He thinks this will create a good buying opportunity here that could double in the next 3-5 years. Yield 2.97% (Analysts’ price target is $55.13)
COMMENT
If you're in it, consider a longer term hold. If you don't have the patience for the headline risk, sell and move on. Lawsuit provides an excellent entry point, as with JNJ. Challenge is it sells big equipment, which has a long sales cycle. Attractively priced at these levels.
Showing 1 to 15 of 38 entries

Koninklijke Philips Electronics(PHG-N) Rating

Ranking : 3 out of 5

Star iconStar iconStar iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 3

Total Signals / Votes : 3

Stockchase rating for Koninklijke Philips Electronics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Koninklijke Philips Electronics(PHG-N) Frequently Asked Questions

What is Koninklijke Philips Electronics stock symbol?

Koninklijke Philips Electronics is a American stock, trading under the symbol PHG-N on the New York Stock Exchange (PHG). It is usually referred to as NYSE:PHG or PHG-N

Is Koninklijke Philips Electronics a buy or a sell?

In the last year, 3 stock analysts published opinions about PHG-N. 0 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Koninklijke Philips Electronics.

Is Koninklijke Philips Electronics a good investment or a top pick?

Koninklijke Philips Electronics was recommended as a Top Pick by on . Read the latest stock experts ratings for Koninklijke Philips Electronics.

Why is Koninklijke Philips Electronics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Koninklijke Philips Electronics worth watching?

3 stock analysts on Stockchase covered Koninklijke Philips Electronics In the last year. It is a trending stock that is worth watching.

What is Koninklijke Philips Electronics stock price?

On 2025-04-25, Koninklijke Philips Electronics (PHG-N) stock closed at a price of $25.03.